PTEN p.Ser170Arg
c.508A>C · rs1554900534 · VCV569301
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9999 | likely pathogenic ✓ concordant with ClinVar · top 8% in PTEN |
|---|---|---|
| REVEL | 0.982 | strongly pathogenic-leaning |
| SaProt | LLR -16.57 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 2.9, phastCons 1 |
| Regional constraint | o/e 0.51 | unconstrained · MANE · 32 kb · p 4.1e-17 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- PTEN
- Protein
- p.Ser170Arg
- Coding
- c.508A>C
- MANE Select
- NM_000314
- dbSNP
- rs1554900534
- Type
- single nucleotide variant
- Location
- chr10:87952133 (GRCh38)
- Gene constraint
- LOEUF 0.685 · pLI 0.05 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 83.76 · 12 PDB
- Residue 170
- an α-helix; the phosphatase tensin-type domain; a UniProt-annotated variant site (in mcephas); a UniProt-annotated variant site (loss of phosphatase activity towards ins(1,3,4,5)p4; retains ability to bind phospholipid membranes); a UniProt-annotated variant site (in cws1; severely reduced protein phosphatase activity; loss of phosphatase activity towards ins(1,3,4,5)p4)
Disease context
PTEN hamartoma tumor syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Cowden syndrome 1hereditary neoplastic syndrome
For PTEN hamartoma tumor syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (Worldwide)
Similar variants
- PTEN p.Ser170Asn Likely pathogenic ★★ same residue
- PTEN p.Ser170Ile Pathogenic/Likely pathogenic ★★ same residue
- PTEN p.Ser170Thr Likely pathogenic ★ same residue
- PTEN p.Ser170Cys Uncertain significance ★ ⚠ same residue
- PTEN p.Ser170Gly Uncertain significance ★ ⚠ same residue
- PTEN p.Ser170= Benign ★ same residue
- PTEN p.Ser170fs Pathogenic ★★ same residue
- PTEN c.1026+1G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pten-p-ser170arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown